TG BIOCHEMICALS K/S: Financial statements 2015
CVR: 34702136
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
TG BIOCHEMICALS K/S (CVR 34702136) has filed annual accounts for 2015. In 2015, the company reported revenue of EUR 379,456 and a net result of EUR 368,176 compared with EUR 5,327,282 the year before. That is a decrease of 99.7% compared with the year before. The profit margin was 97%. Equity in the 2015 report amounted to EUR 443,601. The solvency ratio was 7%.
- Revenue
- EUR 379,456
- Gross Profit
- EUR 379,456
- Profit/Loss
- EUR 368,176
- Equity
- EUR 443,601
- Total Assets
- EUR 6,330,395
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | 379K EUR | 379K EUR | 368K EUR | 444K EUR | - |
| 2014 | 115.6M EUR | 6M EUR | 5.3M EUR | 5.5M EUR | - |
Official annual report
How creditworthy is TG BIOCHEMICALS K/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
TG BIOCHEMICALS K/S has published its annual report for 2014. Revenue came to DKK 115,606,017, and the net result was DKK 5,327,282.
As of March 16, 2015, Giuseppe Spagnoli is registered as director of TG BIOCHEMICALS K/S.
As of March 16, 2015, Giuseppe Spagnoli has stepped down as director of TG BIOCHEMICALS K/S.
About TG BIOCHEMICALS K/S
TG BIOCHEMICALS K/S was a Danish company of the type Kommanditselskab based in Glostrup, founded in 2012. The company has been dissolved on 6 January 2020. The company was registered under the industry Engroshandel med kemiske produkter. According to the 2018 annual report, the company had an average of 1 employee. In 2018, the company reported a gross profit of EUR 390,567 and a net result of EUR 16,435 compared with EUR 420,731 the year before. Equity in the 2018 report amounted to EUR 1,263,337.
